The metabolic function of cyclin D3–CDK6 kinase in cancer cell survival

被引:0
|
作者
Haizhen Wang
Brandon N. Nicolay
Joel M. Chick
Xueliang Gao
Yan Geng
Hong Ren
Hui Gao
Guizhi Yang
Juliet A. Williams
Jan M. Suski
Mark A. Keibler
Ewa Sicinska
Ulrike Gerdemann
W. Nicholas Haining
Thomas M. Roberts
Kornelia Polyak
Steven P. Gygi
Nicholas J. Dyson
Piotr Sicinski
机构
[1] Dana-Farber Cancer Institute,Department of Cancer Biology
[2] Harvard Medical School,Department of Genetics
[3] Massachusetts General Hospital Cancer Center,Department of Cell Biology
[4] Harvard Medical School,Department of Biological Chemistry and Molecular Pharmacology
[5] Harvard Medical School,Department of Chemical Engineering
[6] Novartis Institutes for Biomedical Research,Department of Oncologic Pathology
[7] Massachusetts Institute of Technology,Department of Pediatric Oncology
[8] Dana-Farber Cancer Institute,Division of Pediatric Hematology and Oncology
[9] Dana-Farber Cancer Institute,Department of Medical Oncology
[10] Children’s Hospital,undefined
[11] Broad Institute of MIT and Harvard,undefined
[12] Dana-Farber Cancer Institute,undefined
来源
Nature | 2017年 / 546卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The cyclin D3–CDK6 kinase complex, which is overactive in some cancers, inhibits two key glycolysis enzymes and thereby enhances the levels of antioxidants in cells, promoting tumour cell survival.
引用
收藏
页码:426 / 430
页数:4
相关论文
共 50 条
  • [1] The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival
    Wang, Haizhen
    Nicolay, Brandon N.
    Chick, Joel M.
    Gao, Xueliang
    Geng, Yan
    Ren, Hong
    Gao, Hui
    Yang, Guizhi
    Williams, Juliet A.
    Suski, Jan M.
    Keibler, Mark A.
    Sicinska, Ewa
    Gerdemann, Ulrike
    Haining, W. Nicholas
    Roberts, Thomas M.
    Polyak, Kornelia
    Gygi, Steven P.
    Dyson, Nicholas J.
    Sicinski, Piotr
    NATURE, 2017, 546 (7658) : 426 - +
  • [2] Targeting cyclin D3/CDK6 activity for treatment of Parkinson's disease
    Alquezar, Carolina
    Barrio, Estibaliz
    Esteras, Noemi
    de la Encarnacion, Ana
    Bartolome, Fernando
    Molina, Jose A.
    Martin-Requero, Angeles
    JOURNAL OF NEUROCHEMISTRY, 2015, 133 (06) : 886 - 897
  • [3] Overexpression of Cdk6–cyclin D3 highly sensitizes cells to physical and chemical transformation
    Qiuhong Chen
    Jie Lin
    Shigeki Jinno
    Hiroto Okayama
    Oncogene, 2003, 22 : 992 - 1001
  • [4] Cyclin-dependent kinase 6 overexpression in epidermis of transgenic mice results in increase cdk6/cyclin D3 complexes, keratinocyte proliferation and apoptosis
    Wang, Xian
    Sistrunk, Christopher
    Rodriguez-Puebla, Marcelo
    CANCER RESEARCH, 2009, 69
  • [5] ROLE OF CYCLIN-DEPENDENT KINASE 6 (CDK6) IN PLATELET FUNCTION AND HEMOSTASIS IN MICE
    Hurtado, B.
    Bellido-Martin, L.
    Escolar, G.
    Garcia de Frutos, P.
    THROMBOSIS RESEARCH, 2014, 133 : S20 - S20
  • [6] Role of cyclin dependent kinase 6 (cdk6) in cardiomyocyte cell cycle progression.
    Qian, J
    Fareed, F
    Skopicki, HA
    CIRCULATION, 1998, 98 (17) : 262 - 262
  • [7] CBX3 promotes colon cancer cell proliferation by CDK6 kinase-independent function during cell cycle
    Fan, Yao
    Li, Haiping
    Liang, Xiaolong
    Xiang, Zheng
    ONCOTARGET, 2017, 8 (12) : 19934 - 19946
  • [8] Cyclin-dependent kinase 6 (CDK6) is a candidate diagnostic biomarker for early non-small cell lung cancer
    Gong, Wangang
    Wang, Lifang
    Zheng, Zhiguo
    Chen, Wenhu
    Du, Peng
    Zhao, Hongguang
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (01) : 95 - +
  • [9] Cdk6–cyclin D3 activity in murine ES cells is resistant to inhibition by p16INK4a
    Renate Faast
    Josephine White
    Peter Cartwright
    Lesley Crocker
    Boris Sarcevic
    Stephen Dalton
    Oncogene, 2004, 23 : 491 - 502
  • [10] IDENTIFICATION OF G(1) KINASE-ACTIVITY FOR CDK6, A NOVEL CYCLIN-D PARTNER
    MEYERSON, M
    HARLOW, E
    MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (03) : 2077 - 2086